This demonstrated that the proportion of pathogens with seroprotective antibody titers was stable over time after CD19/20-CARTx and modestly increased after BCMA-CARTx (although the increase did not reach statistical significance).
← all excerpts
Influence of B cell-lineage targeted CAR-T cell therapy on humoral immunity and vaccine-induced antibody response.
1
—
—